Request for Information - Centers for Disease Control and Prevention / National Institute of Occupational Safety and Health / World Trade Center Health Program
ID: RFI-CDC-75D301-01Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

All Other Outpatient Care Centers (621498)

PSC

MEDICAL- GENERAL HEALTH CARE (Q201)
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is issuing a Request for Information (RFI) to gather industry feedback on a draft Performance Work Statement (PWS) related to the operation of a Survivor Clinical Center of Excellence (CCE) for individuals affected by the September 11, 2011 terrorist attacks in the New York metropolitan area. The objective of this procurement is to ensure continued health monitoring and treatment for eligible survivors, with the CDC seeking input on the clarity, completeness, and feasibility of the draft PWS to enhance the potential procurement process. This initiative is critical for providing necessary healthcare services to a vulnerable population, and the feedback received will help refine the evaluation techniques for selecting qualified vendors. Interested parties must submit their feedback to Serina Allingham at xog9@cdc.gov by 12:00 EST on January 31, 2025, and should note that this RFI is for information purposes only and does not constitute a solicitation for proposals.

    Point(s) of Contact
    Serina Allingham
    17704484602
    xog9@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    World Trade Center Health Program - Outreach and Education
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking qualified vendors to provide outreach and education services for the World Trade Center (WTC) Health Program. The primary objective is to enhance awareness and participation among underrepresented populations affected by the September 11 attacks, particularly focusing on non-English speakers and low-income survivors. This initiative is crucial for ensuring that eligible individuals receive necessary medical treatment and monitoring, as current enrollment is significantly low compared to the estimated number of impacted individuals. Interested parties must submit their capability statements by February 3, 2025, and can direct inquiries to Joseph Jones at zjb2@cdc.gov. The contract is expected to run from June 1, 2025, to May 31, 2030, with a strong emphasis on culturally sensitive engagement and measurable outreach success.
    CDC WORLD TRADE CENTER (WTC) HEALTH PROGRAM PHARMACY BENEFITS MANAGER
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified vendors to provide Pharmacy Benefits Manager (PBM) services for the World Trade Center (WTC) Health Program, which supports responders and survivors affected by the 9/11 attacks. The procurement aims to operationalize a three-year contract that includes a 12-month implementation period, a peak operational phase, and a transition-out period, all while ensuring compliance with federal regulations and managing pharmacy benefits for a limited healthcare program. The PBM will be responsible for developing a pharmacy network, implementing electronic claims processing systems, conducting audits, and maintaining transparent pricing, among other tasks, to ensure optimal care for enrollees. Interested parties must submit their qualifications by February 14, 2025, and can direct inquiries to Laurie Presley at xnp0@cdc.gov.
    World Trade Center Health Program Third-Party Administrator (TPA)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for a Third-Party Administrator (TPA) to support the World Trade Center (WTC) Health Program. The TPA will be responsible for managing enrollment applications, maintaining member information, overseeing provider networks, administering health benefits, and processing medical claims for individuals affected by the September 11 attacks. This program is crucial for delivering comprehensive healthcare services to approximately 132,000 members, ensuring they receive the necessary medical monitoring and treatment for WTC-related conditions. Interested offerors must submit their proposals by April 11, 2025, with a pre-proposal conference scheduled for January 22, 2025, and can direct inquiries to Joshua Houston at jhouston@cdc.gov.
    World Trade Center Health Program Third-Party Administrator (TPA)
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking a qualified third-party administrator (TPA) for the World Trade Center (WTC) Health Program. The TPA will be responsible for managing enrollment applications, maintaining member information, overseeing a call center, and processing medical claims related to WTC-related health conditions for individuals affected by the September 11th attacks. This program is crucial for providing medical monitoring and treatment to eligible participants, ensuring they receive the necessary care and support. Interested parties should note that the solicitation is anticipated to be released on January 16, 2025, with proposals due by April 11, 2025. For further inquiries, contact Joshua Houston at jhouston@cdc.gov.
    CDC DFWED NARST Sensititre Supplies
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    FY2025 CDC NIOSH Mine Safety and Health Research Broad Agency Announcement
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking proposals for the FY2025 Broad Agency Announcement (BAA) focused on enhancing mine safety and health through innovative research and development. The primary objective is to develop and commercialize technologies that address safety and health issues in mining environments, with an emphasis on real-time monitoring of coal dust and respirable crystalline silica. This initiative is critical for improving occupational safety in the mining sector, reflecting the government's commitment to advancing worker protection through technological solutions. Interested parties must submit concept papers by January 20, 2025, with total funding expected to range from $2 to $5 million for 6 to 10 contracts, averaging between $200,000 and $300,000 each. For further inquiries, contact Eugene Marrone at xve9@cdc.gov.
    Pre-Solicitation FY 2025 CDC OS Emerging Public Health Priorities BAA
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is preparing to issue a Fiscal Year 2025 Broad Agency Announcement (BAA) for Applied Research aimed at addressing Emerging Public Health Priorities. This initiative seeks innovative research proposals in various areas, including infectious disease surveillance, wastewater surveillance, and substance use disorder recovery, to enhance public health strategies and responses to emerging threats. The BAA will be open for full and open competition, with a tentative issuance date of December 30, 2024, and a due date for concept papers set for January 30, 2025. Interested contractors must ensure they are registered in the System for Award Management (SAM) to be eligible for award, and further details will be available on SAM.gov.
    A--Resource for the Collection of Human Tissues, Cells, Biofluids and Epidemiologi
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) National Cancer Institute (NCI), is seeking capability statements from organizations for a contract focused on the collection and evaluation of human tissues, cells, and biofluids from donors with epidemiologic profiles. This initiative aims to support molecular epidemiology studies related to various cancers, including lung, breast, liver, and pancreatic cancer, and involves tasks such as participant recruitment, biological specimen collection, and data processing while ensuring compliance with ethical regulations. The contract, anticipated to last five years, builds on efforts initiated in 1996 and emphasizes the importance of delivering viable tissues promptly and maintaining data confidentiality. Interested organizations, excluding the current provider, must submit their qualifications by February 18, 2025, and can contact Whitney D. Monkama at whitney.monkam@nih.gov or +1 240 276 5446 for further information.
    Updated: Save the Date for the CDC Small Business Engagement Summit: Ignite and Inspire
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is hosting the Small Business Engagement Summit: Ignite and Inspire on February 27, 2025, at the CDC Roybal Campus in Atlanta, Georgia. This one-day event aims to foster collaboration between the small business community and CDC’s Centers/Institutes/Offices (CIOs), providing insights into upcoming goals and requirements for fiscal years 2025 and 2026, along with opportunities for capability briefings with CDC contracting officers. This summit is a significant opportunity for small businesses to engage with government entities and explore potential collaborations on public health initiatives. Registration for in-person attendance opens in early January and closes on February 13, 2025, with limited spots available; a virtual attendance option is also offered. For further inquiries, interested parties can contact Rotravius Burch at vwa8@cdc.gov or Sherrie Randall at iom2@cdc.gov.
    Serological Assays for the Detection and Characterization of Influenza Viruses
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human serum samples and developing new serology platforms that are comparable to existing methods. This initiative is crucial for enhancing influenza surveillance and vaccine effectiveness studies, addressing ongoing public health challenges. Interested parties must submit a Letter of Interest by 2:00 PM EST on February 7, 2025, and can contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further information.